T1	Premise 47 195	A 37-year-old woman with extensive ulcerative colitis presents a severe flare-up for which treatment with prednisone at a dose of 1 mg/kg is started
T2	Premise 197 258	After one week of treatment, the patient shows no improvement
T3	Claim 313 397	Emergency subtotal colectomy and in a second time prostectomy and ileoanal reservoir
T4	Claim 402 453	Associate an immunosuppressant such as azathioprine
T5	Claim 458 562	Associate mesalazine in doses of 4g per day orally and rectal triamcinolone 1 application every 12 hours
T6	Claim 567 598	Intravenous cyclosporine 2mg/kg
T7	Claim 603 673	Treatment with etanercept (an anti-TNFa antibody) should be considered
T8	Claim 693 850	When a severe flare does not respond to iv corticosteroid therapy at full doses (1mg/kg body weight), it is necessary to switch to cyclosporine or infliximab
R1	Support Ent1:T8 Ent2:T6	
T9	Claim 852 940	Etanercept is not approved in Europe for inflammatory bowel disease (for the time being)
R2	Attack Ent1:T9 Ent2:T7	
T10	Treatment 824 836	cyclosporine
T11	Treatment 840 850	infliximab
T12	Treatment 852 862	Etanercept
T13	Treatment 313 341	Emergency subtotal colectomy
T14	Treatment 351 374	second time prostectomy
T15	Treatment 379 397	ileoanal reservoir
T16	Treatment 441 453	azathioprine
T17	Treatment 468 508	mesalazine in doses of 4g per day orally
T18	Treatment 513 562	rectal triamcinolone 1 application every 12 hours
T19	Treatment 567 598	Intravenous cyclosporine 2mg/kg
T20	Treatment 618 652	etanercept (an anti-TNFa antibody)
